Galmed buys Colospan as its FDA Breakthrough Device faces a pivotal clinical test
Galmed Pharmaceuticals has acquired Colospan and its CG-100 colorectal bypass device, but European adoption, pivotal United States evidence and financing will determine whether the micro-cap company can create a sustainable medtech business.